STERIS’ (TSE:STE – Free Report) – Analysts at Atb Cap Markets reduced their Q3 2024 earnings estimates for shares of STERIS’ in a research report issued to clients and investors on Tuesday, October 1st. Atb Cap Markets analyst W. Syed now forecasts that the company will post earnings of $0.19 per share for the quarter, down from their previous estimate of $0.29. Atb Cap Markets also issued estimates for STERIS’’s FY2024 earnings at $0.77 EPS, Q1 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.31 EPS and Q1 2026 earnings at $0.40 EPS.
STERIS’ Price Performance
STERIS’ (TSE:STE – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported C$0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$0.12 by C$0.02. The firm had revenue of C$231.38 million during the quarter, compared to the consensus estimate of C$226.20 million.
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Further Reading
- Five stocks we like better than STERIS’
- The Basics of Support and Resistance
- When Is the Best Time to Invest in Mutual Funds?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Is NVIDIA Stock in a Correction or Consolidation?
- Business Services Stocks Investing
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
